Apogee Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $151.9M |
| FY2023 | — | — | $118.3M |
| FY2024 | — | — | $141.8M |
| FY2025 | — | — | $131.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $151.9M |
| FY2023 | — | — | $118.3M |
| FY2024 | — | — | $141.8M |
| FY2025 | — | — | $131.5M |